Insider Transactions in Q2 2025 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,950
-4.15%
|
$671,250
$75.23 P/Share
|
|
Jun 16
2025
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,950
+3.98%
|
$528,050
$59.26 P/Share
|
|
Jun 03
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Indirect |
967
-10.11%
|
$74,459
$77.32 P/Share
|
|
Jun 02
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
2,570
-4.86%
|
$197,890
$77.4 P/Share
|
|
May 30
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Indirect |
16,099
-62.73%
|
$1,239,623
$77.21 P/Share
|
|
May 22
2025
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,500
-4.29%
|
$112,500
$75.08 P/Share
|
|
May 16
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
5,815
+18.47%
|
-
|
|
May 16
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
5,815
-6.7%
|
-
|
|
May 13
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
2,771
+12.25%
|
-
|
|
May 13
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
2,771
-3.09%
|
-
|
|
May 11
2025
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,860
-3.09%
|
$208,780
$73.68 P/Share
|
|
May 11
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
988
-0.48%
|
$72,124
$73.68 P/Share
|
|
May 11
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,200
-2.92%
|
$87,600
$73.68 P/Share
|
|
May 11
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-1.02%
|
$19,783
$73.68 P/Share
|
|
May 11
2025
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-1.63%
|
$42,340
$73.68 P/Share
|
|
May 11
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-1.52%
|
$59,568
$73.68 P/Share
|
|
May 09
2025
|
Leslie C. Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+34.89%
|
-
|
|
May 09
2025
|
David T Feinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+37.68%
|
-
|
|
May 09
2025
|
Kieran Gallahue Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,682
+34.89%
|
-
|
|
May 09
2025
|
Heisz Leslie Stone Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+9.51%
|
-
|
|
May 09
2025
|
Paul A Laviolette Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+19.79%
|
-
|
|
May 09
2025
|
Steven R Loranger Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,682
+3.49%
|
-
|
|
May 09
2025
|
Ramona Sequeira Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+23.19%
|
-
|
|
May 09
2025
|
Nicholas J Valeriani Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,564
+6.56%
|
-
|
|
May 09
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
330
-1.22%
|
$24,420
$74.42 P/Share
|
|
May 09
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
330
+1.21%
|
$14,850
$45.28 P/Share
|
|
May 09
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,250
-21.49%
|
$832,500
$74.4 P/Share
|
|
May 09
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+17.69%
|
$506,250
$45.28 P/Share
|
|
May 08
2025
|
Annette Bruls CVP, EMEACLA |
BUY
Grant, award, or other acquisition
|
Direct |
6,200
+30.27%
|
-
|
|
May 08
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
4,225
+13.7%
|
-
|
|
May 08
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Grant, award, or other acquisition
|
Direct |
8,375
+13.48%
|
-
|
|
May 08
2025
|
Larry L Wood Global President TAVR & Surg |
BUY
Grant, award, or other acquisition
|
Direct |
11,050
+5.05%
|
-
|
|
May 08
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
4,122
+19.45%
|
-
|
|
May 08
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
4,122
-4.27%
|
-
|
|
May 08
2025
|
Bernard J Zovighian CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,550
+31.09%
|
-
|
|
May 08
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+24.59%
|
-
|
|
May 08
2025
|
Daveen Chopra CVP, TMTT |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+20.55%
|
-
|
|
May 08
2025
|
Wayne Markowitz GM & SVP, Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
3,350
+21.34%
|
-
|
|
May 08
2025
|
Andrew M. Dahl SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,335
+29.15%
|
-
|
|
May 07
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
851
-1.84%
|
$62,974
$74.92 P/Share
|
|
May 07
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
819
-0.41%
|
$60,606
$74.92 P/Share
|
|
May 07
2025
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,253
-7.43%
|
$314,722
$74.92 P/Share
|
|
May 07
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,406
-4.83%
|
$104,044
$74.92 P/Share
|
|
May 07
2025
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
627
-2.32%
|
$46,398
$74.92 P/Share
|
|
May 07
2025
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-3.23%
|
$22,200
$74.92 P/Share
|
|
May 07
2025
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Open market or private sale
|
Direct |
268
-2.8%
|
$20,100
$75.08 P/Share
|
|
May 06
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
1,036
+7.41%
|
-
|
|
May 06
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
1,036
-1.78%
|
-
|
|
May 05
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
1,482
+11.06%
|
-
|
|
May 05
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Direct |
5,980
-9.31%
|
$442,520
$74.91 P/Share
|